Loading company…
Perpetual Medicines develops peptide drugs and computational drug discovery platforms.
Perpetual Medicines researches and develops peptide drugs and computational design and automated synthesis platforms. Its products target oncology, autoimmune diseases, and metabolic diseases. Founded in 2023, the company is based in Shanghai, China, with operations in Boston, USA. In December 2023, it raised USD 8 million in seed funding led by Chengwei Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in